Literature DB >> 6405632

Neuroendocrine abnormalities in bulimia.

H E Gwirtsman, P Roy-Byrne, J Yager, R H Gerner.   

Abstract

The authors examined the relationship of clinical variables, family history, and neuroendocrine function in 18 bulimic patients. Twelve of 18 patients (67%) showed abnormalities of cortisol suppression, and 8 of 10 (80%) showed blunted thyrotropin-releasing hormone (TRH) tests. These findings suggest that neuroendocrine abnormalities identified previously in anorexia nervosa are not solely an artifact of low weight and, further, that eating disorders and affective disorders may share neurochemical similarities.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405632     DOI: 10.1176/ajp.140.5.559

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

1.  A comparison of demographic, behavioral, and ego function data in borderline and eating disorder patients.

Authors:  T E Smith; N A Burkey; J Nawn; M C Reif
Journal:  Psychiatr Q       Date:  1991

Review 2.  The role of serotonin in eating disorders.

Authors:  S F Leibowitz
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 3.  Current perspectives on drug therapies for anorexia nervosa and bulimia nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

4.  The comorbidity of eating disorders and personality disorders: a meta-analytic review of studies published between 1983 and 1998.

Authors:  J H Rosenvinge; M Martinussen; E Ostensen
Journal:  Eat Weight Disord       Date:  2000-06       Impact factor: 4.652

5.  Differential dynamic responses of luteinizing hormone to gonadotropin releasing hormone in patients affected by bulimia nervosa-purging versus non-purging type.

Authors:  C E Ramacciotti; L Guidi; E Bondi; E Coli; L Dell'Osso; S Pistoia; E Pucci
Journal:  Eat Weight Disord       Date:  1997-09       Impact factor: 4.652

6.  Plasma B-endorphin resistance to dexamethasone suppression in obese patients.

Authors:  F Facchinetti; C Giovannini; F Petraglia; C Barletta; G Comitini; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

7.  Comparative efficacy and acceptability of selective serotonin reuptake inhibitor antidepressants for binge eating disorder: A network meta-analysis.

Authors:  Hanying Duan; Lijun Zhu; Min Li; Xinyue Zhang; Beilin Zhang; Shaokuan Fang
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.